A randomized double blind study to evaluate efficacy of palonosetron with dexamethasone versus palonosetron alone for prevention of postoperative and postdischarge nausea and vomiting in subjects undergoing laparoscopic surgeries with high emetogenic risk

American Journal of Therapeutics

Volumn 19, Issue 5, 2012, Pages 324-329

  Blitz, Jeanna D ^a   Haile, Michael ^a   Kline, Richard ^a   Franco, Lola ^a   Didehvar, Sorosch ^a   Leon Pachter, H ^a   Newman, Elliot ^a   Bekker, Alex ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 HT3 receptor antagonist; emetogenic; laparoscopic surgery; postdischarge nausea and vomiting; postoperative nausea and vomiting

Indexed keywords

DEXAMETHASONE; PALONOSETRON;

ADULT; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; POSTDISCHARGE NAUSEA AND VOMITING; POSTOPERATIVE NAUSEA AND VOMITING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TREATMENT OUTCOME;

ADULT; ANESTHESIA, GENERAL; ANTIEMETICS; DEXAMETHASONE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INCIDENCE; ISOQUINOLINES; LAPAROSCOPY; MALE; POSTOPERATIVE NAUSEA AND VOMITING; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUINUCLIDINES; RISK FACTORS; TIME FACTORS;

EID: 84866405197     PISSN: 10752765     EISSN: 15363686     Source Type: Journal    
DOI: 10.1097/MJT.0b013e318209dff1     Document Type: Article

References (17)

1. Rajeeva B, Bhardwaj N, Batra YK, et al. Comparison of ondansetron with ondansetron with dexamethasone in prevention of PONV in diagnostic laparoscopy. Can J Anaesth. 1999;46:40-44.
2. Kenny GNC. Risk factors for postoperative nausea and vomiting. Anaesthesia. 1994;49(Suppl):6-10.
3. Gupta A, Wu CL, Elkassabany N, et al. Dose the routine prophylactic use of antiemetics affect the incidence of postdischarge nausea and vomiting following ambulatory surgery? Anesthesiology. 2003; 99:488-495.
4. Carroll NV, Miederhoff P, Cox FM, et al. Postoperative nausea and vomiting after discharge from outpatient surgery centers. Anesth Analg. 1995;80:903-909.
5. Le TP, Gan TJ. Update on the management of postoperative nausea and vomiting and postdischarge nausea and vomiting in ambulatory surgery. Anesthesiol Clin. 2010;28:225-249.
6. White PF, Sacan O, Nuangchamnong N, et al. The relationship between patient risk factors and early versus late postoperative emetic symptoms. Anesth Analg. 2008; 107:459-463.
7. Apfel CC, Laara E, Koivuranta M, et al. A simplified risk score for predicting postoperative nausea and vomiting. Anesthesiology. 1999;91:693-700.
8. Kovac AL, Eberhart L, Kotarski J, et al. A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonsetron versus placebo in preventing postoperative nausea and vomiting over a 72-hours period. Anesth Analg. 2008;107:439-444.
9. Rojas C, Stathis M, Thomas AG, et al. Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor. Anesth Analg. 2008;107:469-478.
10. Tang J, D'Angelo R, White PF, et al. The efficacy of RS-25259, a long-acting selective 5-HT3 receptor antagonist, for preventing postoperative nausea and vomiting after hysterectomy procedures. Anesth Analg. 1998;87: 462-467.
11. Gan TJ. Selective serotonin 5-HT3 receptor antagonists for postoperative nausea and vomiting. Are they all the same? CNS Drugs. 2005;19:225-238.
12. Apfel CC, Korttila K, Abdalia M. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med. 2004;350:2441-2451.
13. Scuderi PE, James RL, Harris L, et al. Multimodal antiemetic management prevents early postoperative vomiting after outpatient laparoscopy. Anesth Analg. 2009;91:1408-1414.
14. Decker M, DeMeyer ES, Kisko D. Measuring the maintenance of daily life activities using the functional living index-emesis (FLIE) in patients receiving moderately emetogenic chemotherapy. J Support Oncol. 2006;4: 35-41.
15. Candiotti KA, Kovac AL, Melson TI, et al. A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonsetron versus placebo in preventing postoperative nausea and vomiting. Anesth Analg. 2008;107:445-451.
16. Musso M, Scalone R, Bonanno V, et al. Palonosetron (Aloxi) and dexamethasone for the prevention of acute and delayed nausea and vomiting in patients receiving multiple-day chemotherapy. Support Care Cancer. 2009;17: 205-209.
17. Henzi I, Walder B, Tramer MR. Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg. 2000;90: 186-194.